🔎 Trials Near Me

Home › Lung Cancer › Texas › Irving

Lung Cancer clinical trials in Irving, TX

6 studies for Lung Cancer are looking for participants at sites in and around Irving (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

RecruitingPhase 3
  • US Oncology Investigational Products Center (IPC), Irving
  • US Oncology Investigational Products Center, Irving
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07222566

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • NEXT Oncology - Irving, Irving
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06618287

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

RecruitingPhase 1/2
  • NEXT Dallas, Irving
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

RecruitingPhase 1/2
  • NEXT Oncology Dallas, Irving
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT06162221

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

RecruitingPhase 1/2
  • NEXT Dallas, Irving
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT06922591

About Lung Cancer

Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.

More about Lung Cancer on MedlinePlus

Lung Cancer trials in other cities

Other studies in Irving

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.